Michael Kalos

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

David L. Porter, Bruce L. Levine, Michael Kalos et al. · New England Journal of Medicine · 2011 · 3.5K citations · Full text

Life Sciences, Hematology, Immunology +17

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

Stephan A. Grupp, Michael Kalos, David M. Barrett et al. · New England Journal of Medicine · 2013 · 3.5K citations · Full text

Life Sciences, Hematology, Immunology +16

T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

Michael Kalos, Bruce L. Levine, David L. Porter et al. · Science Translational Medicine · 2011 · 2.4K citations · Full text

Life Sciences, Immunology, Oncology +17

Gene Editing of <i>CCR5</i> in Autologous CD4 T Cells of Persons Infected with HIV

Pablo Tebas, David Stein, Winson W. Tang et al. · New England Journal of Medicine · 2014 · 1.3K citations · Full text

Life Sciences, Immunology, Molecular Genetics +16

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma

Gerald P. Linette, Edward A. Stadtmauer, Marcela V. Maus et al. · Blood · 2013 · 1.2K citations

Life Sciences, Immunology, Oncology +16